Skip to content
  1. Home/
  2. Latest news/
  3. How Johnson & Johnson Is Helping Mentor the Next Generation of Global Women Leaders

Paying it forward: How Johnson & Johnson is helping mentor the next generation of global women leaders

Last month, the company hosted two young businesswomen from India and Zimbabwe participating in the Global Women’s Mentoring Partnership. Watch moments from their two-week stay in this behind-the-scenes video.

As the popular saying goes: “It takes a village.” The same could be said of cultivating the leaders of tomorrow.

That’s why, for 12 years running, the Global Women’s Mentoring Partnership—sponsored by Fortune and the U.S. State Department, in conjunction with the Vital Voices Global Partnership—has paired businesswomen from around the world with top American female executives.

The goal: provide these future international leaders with lifelong mentors, top-notch professional skills and new inspiration they can take back to their companies and communities.

Earlier this month, two such up-and-comers—Cynthia Tendai Mugwira, Legal and Corporate Affairs Manager of the Medicines Control Authority of Zimbabwe; and Chaitali Das, Managing Trustee of the Rakshak Foundation Kolkata in India—spent two weeks at Johnson & Johnson, where they shadowed company leaders, received energy-management training tailored for women leaders from the Johnson & Johnson Human Performance Institute and much more.

Get a glimpse of what they learned during their trip—and what they hope to accomplish when they return home—in this behind-the-scenes video.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.